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Isolating Antibiotic-Producing Bacteria From Soil
Michelle Santiago and Dr. Lori Scott
INTRODUCTION
The misuse of antibiotics, such as persistent use or simply not 
finishing the prescribed dosage, and nosocomial (medically 
acquired bacteria) pathogens can be detrimental to the health of 
an individual as it causes bacteria, specifically the ESKAPE 
pathogens, to become resistant to such antibiotics. The ESKAPE 
pathogens (Enterococcus faecium, Staphylococcus aureus, 
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas 
aeruginosa, and Enterobacter species) are those that make up 
most of the antibiotic-resistant infections in medical settings (1). 
As a way to help fight off those bacteria, emerging strategies have 
been developed, such as antibiotic combinations, bacteriophage 
therapy, antimicrobial peptide therapy, and photodynamic light 
therapy (2). Unfortunately, these ESKAPE pathogens are 
becoming more resistant and there are simply not enough 
antibiotic combinations to successfully eliminate the strains (2). 
Microbes are proliferating and revolutionizing much faster than 
antibiotics being discovered, further contributing to this crisis. 
Due to this complication, the Tiny Earth Project was created. The 
project focuses on educating students about the antibiotic 
adversity and to find novel antibiotics from soil (1). For this 
projects, ESKAPE-like strains will be utilized to minimize 
exposure to pathogens, and the TEPI protocol was followed 
unless otherwise noted. Contribution to the TEPI project will 
allow us to discover potential antibiotic-producing bacteria from 
soil. 
Our soil isolates will be tested on two ESKAPE-like strains: 
Escherichia coli and Bacillus subtilis. E. coli is a safe relative of 
Klebsiella pneumoniae and is gram-negative, rod-shaped (bacilli), 
and use flagella for motility. E. coli grown on solid medium will 
display round, dull colonies that are white in color with entire 
margins (3). Most E. coli can be harmless and a part of the normal 
flora in an individual, but some strains can cause harm, such as 
diarrhea or urinary tract infections (UTI) (3).
Bacillus subtilis is not considered pathogenic (unless exposed to 
immunocompromised individuals) and is commonly used as a 
fungicide/pesticide in farms because of its spore-forming nature 
(4). B. subtilis, as given away by its name, is also bacilli in shape. 
This strain is Gram-positive, therefore, there is a thick layer of 
peptidoglycan in its cell wall. B. subtilis has an interesting colony 
morphology as it grows rapidly, and the edges are rough and 
irregular (5). Our contribution to the TEPI project is vital in order 
to find potential antibiotic producers from soil. As more 
antibiotics are discovered, nosocomial infections will hopefully 
decline and mechanisms to oppose the ESKAPE pathogens will 
be discovered. 
METHODS
Unless described otherwise, the bacterial strains and protocols used 
in this study were provided by the Tiny Earth Project Initiative 
(TEPI) (1).
• Obtained rich soil sample from a garden (depth= 4 in.) at 41.4 
°N, 90.5° E.
• Dilution of soil sample using PBS
• Created spread plates on different media (LB, 10% TSA, PDA). 
Analyzed after 24-72 hours of incubation at 28 ℃
• Master plate created and incubated for 24 hours at 28 ℃
• Tested for antibiotic production using Bacillus subtilis or 
Escherichia coli. Incubated at 28 ℃
• Analyzed for possible “halos” around the isolates placed on 
either B. subtilis or E. coli and created streak plates. Isolates 
were re-streaked again to confirm antibiotic production
• PCR and Gel Electrophoresis (1% agarose) for 30 minutes at 
100 V.
• Gel extraction and sequenced at Iowa Institute of Human 
Genetics, University of Iowa. The primers used were 27F and 
1492R.
• Biochemical tests, including Gram stain, and were performed 
following supplier instructions 
• Used NCBI BLAST for genus analysis.
DISCUSSION
Our bodies are becoming more resistant towards the ESKAPE 
pathogens, along with other pathogens. Due to this antibiotic crisis, 
it was decided to participate in TEPI. The results showed that some 
of the soil isolates inhibited the growth of the other bacteria by 
creating an antibiotic. These two isolates were sequenced and 
proved to be part of the Pseudomonas and Bacillus genus, which are 
common bacteria found in soil (7). B. subtilis is a known antibiotic 
producer, therefore it was anticipated as one of the potential isolate 
products (8). It would be beneficial to isolate the compound that is 
actively responsible for producing the antibiotic using bioassay-
guided isolation, as explained by the TEPI manual. This study 
confirms that soil is home to a diverse population of 
microorganisms that can improve the current antibiotic crisis.  
Fig.1. Successful master plates created from soil isolates were 
incubated for 24 hours at 28 ℃ (A= LB agar, B= 10% TSA, C= PDA). 
These isolates were tested on Escherichia coli and Bacillus subtilis to 
determine if antibiotic-producing activity was present.
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RESULTS
When creating the spread plates of B. subtilis and E. coli to test 
against the soil isolates, it was observed that E. coli grew on LB 
agar but did not grow as well on the more selective mediums (10% 
TSA, PDA). This may be an explanation as to why the isolates did 
not produce an antibiotic against E. coli. Since E. coli did not grow 
well, the isolates might not have been inclined to produce an 
antibiotic in order to compete for resources. Therefore, the only 
inhibition zones were observed against B. subtilis. Of those isolates, 
three were chosen to re-test for antibiotic production. Only two 
confirmed antibiotic production against B. subtilis (MS-9-LB-B. 
subtilis, MS-36-TSA- B. subtilis). Strangely enough, MS-36-TSA 
had originally produced a zone of inhibition on 10% TSA and LB 
agar but when screened again, it only produced it on LB agar. MS-9-
LB-B. subtilis remained consistent as it produced the “halo” on LB 
agar and 10% TSA.
Fig. 2. Second screening of the soil 
iso isolates to confirm antibiotic 
production                                                   production on either B. subtilis 
and/or                                                          and/or E. coli on LB agar and 10% 
TSA                                                             TSA media (A= B. subtilis on 10% 
TSA                                                             TSA, B= B. subtilis on LB, C= E. 
coli                                                               coli on 10% TSA, D= E. coli on LB)                                            
The plates were divided into three 
section                                                         sections: isolate #9 (top), isolate #21 
(middle                                                        (middle), isolate #36 (bottom). #9 
displayed                                                     displayed a strong “halo” in A and B. 
#21                                                              #21 did not display a “halo” in any of 
the                                                               the conditions. #36 displayed a subtle 
halo                                                             “halo” in plate B.
The three isolates that were re-screened (MS-9-LB-B. subtilis, MS-
36-TSA- B. subtilis, MS-21-TSA-B. subtilis) were chosen for PCR 
to isolate the 16s rRNA gene. Instead of diluting the colonies in PBS 
buffer as the protocol called for, the colony was directly placed onto 
sterilized water and transferred onto the IBI Scientific PCR reagents 
and IDT primers. The PCR products of the isolates were observed 
with gel electrophoresis (1% agarose and ran at 100V for 30 min.).
RESULTS (CONTINUED)
Only MS-9-LB-B. subtilis and MS-36-TSA- B. subtilis were chosen 
for gel extraction, sequencing, and biochemical tests, such as gram-
stains, catalase test, among others. The sequencing results were sent 
back a couple of days later This sequence was inserted to the NCBI 
BLAST program to compare it to known microorganism sequences 
(6). The bacterial genus that was mostly related to the 16s rRNA 
sequence of MS-36-TSA- B. subtilis is Pseudomonas. MS-9-LB-B. 
subtilis was mostly related to the Bacillus genus, which is 
interesting because it produced an antibiotic to another 
microorganism of the same genus.
Fig. 3. 16s rRNA sequencing results MS-36-TSA- B. subtilis (top) and MS-9-
LB-B. subtilis (bottom). Isolate #36 is closely related ted the genus 
Pseudomonas and Isolate #9 is related to the Bacillus genus, as determined by 
BLAST (6). 
